Publication:
Effects of Intramuscular Parecoxib Administration on Vasospasm in an Experimental Subarachnoid Hemorrhage Model

dc.contributor.authorCelik, Ozgur
dc.contributor.authorBilginer, Burcak
dc.contributor.authorKorkmaz, Adnan
dc.contributor.authorGurgor, Pinar Naile
dc.contributor.authorBavbek, Murad
dc.contributor.authorOzgen, Tuncalp
dc.contributor.authorZiyal, Ibrahim
dc.contributor.authorIDCelik, Ozgur/0000-0003-3736-8303
dc.date.accessioned2020-06-21T14:40:02Z
dc.date.available2020-06-21T14:40:02Z
dc.date.issued2011
dc.departmentOMÜen_US
dc.department-temp[Celik, Ozgur -- Bilginer, Burcak -- Ozgen, Tuncalp -- Ziyal, Ibrahim] Hacettepe Univ, Sch Med, Dept Neurosurg, Ankara, Turkey -- [Korkmaz, Adnan -- Gurgor, Pinar Naile] Ondokuz Mayis Univ, Dept Histol & Embryol, Sch Med, Samsun, Turkey -- [Bavbek, Murad] Diskapi Yildirim Beyazit Training & Res Hosp, Dept Neurosurg, Minist Hlth, Ankara, Turkeyen_US
dc.description.abstractAim: We examined whether intramuscular parecoxib administration has a preventive or therapeutic effect on vasospasm following experimental subarachnoid hemorrhage (SAH). Materials and Methods: Twenty New Zealand White Rabbits were assigned randomly to one of four groups. Animals in Group I were not subjected to SAH (control group). Animals in all other groups were subjected to SAH. Animals in Group II received no treatment after SAH induction (SAH group). Animals in Group III received intramuscular parecoxib (diluted with saline) injection at 6 and at 30 hours after SAH (treatment group). Animals in Group IV received only intramuscular saline injection at 6 and at 30 hours after SAH (vehicle group). Animals were euthanized by perfusion and fixation 48 hours after SAH induction. Basilar artery cross-sectional areas and wall thicknesses were measured. Statistical comparisons were performed using Kruskal-Wallis and Mann-Whitney U tests. Results: Basilar artery cross-sectional areas in the treatment group were significantly higher than in the SAH or vehicle group (p < .05). Basilar artery wall thickness in the treatment group was significantly smaller than in the SAH or vehicle group (p < .05). Conclusion: Our study revealed that intramuscular administration of parecoxib significantly attenuates vasospasm following experimental SAH.en_US
dc.identifier.doi10.3109/00207454.2011.556284
dc.identifier.endpage322en_US
dc.identifier.issn0020-7454
dc.identifier.issn1563-5279
dc.identifier.issue6en_US
dc.identifier.pmid21348801
dc.identifier.startpage316en_US
dc.identifier.urihttps://doi.org/10.3109/00207454.2011.556284
dc.identifier.urihttps://hdl.handle.net/20.500.12712/17161
dc.identifier.volume121en_US
dc.identifier.wosWOS:000291158900004
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.journalInternational Journal of Neuroscienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectCerebral Vasospasmen_US
dc.subjectCyclooxygenaseen_US
dc.subjectInflammationen_US
dc.subjectParecoxiben_US
dc.subjectSubarachnoid Hemorrhageen_US
dc.titleEffects of Intramuscular Parecoxib Administration on Vasospasm in an Experimental Subarachnoid Hemorrhage Modelen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files